[ad_1]
The president of the European Commission, Ursula von der Leyen, announced that tomorrow she will authorize a contract for up to 300 million doses of vaccine developed by the German company BioNTech and the US company Pfizer. This is the most promising vaccine to date.
“We work tirelessly to provide doses of potential coronavirus vaccines. Tomorrow, the European Commission will authorize a contract for up to 300 million doses of the BioNTech & Pfizer vaccine, the most promising to date.
This is the fourth contract. More will followUrsula von der Leyen wrote on Twitter.
We work tirelessly to secure doses of potential coronavirus vaccines. Morning, @EU_Commission will authorize a contract for up to 300 million doses of the BioNTech & Pfizer vaccine, the most promising to date.
This is the fourth contract. More will follow. Https://t.co/uCJV6Xccz7– Ursula von der Leyen (@vonderleyen) November 10, 2020
The announcement came a day after the two companies said their experimental vaccine was more than 90% effective.
“Once this vaccine is available, our plan is to quickly implement it across Europe. This will be the fourth contract with a pharmaceutical company to buy vaccines. And more will come. Because we need to have a wide portfolio of vaccines based on different technologies.
We have already started working with the Member States to prepare national vaccination campaigns.
I’m almost there. In the meantime, let’s be careful and stay safe,”To adăugat von der Leyen.
The European Commission is negotiating with vaccine manufacturers on behalf of EU countries.
For the most important news of the day, broadcast in real time and presented equally, like our Facebook page!
Follow Mediafax on Instagram to see amazing images and stories from around the world!
The content of the website www.mediafax.ro is intended exclusively for your information and personal use. Is prohibited republish the content of this site in the absence of an agreement from MEDIAFAX. To obtain this agreement, contact us at [email protected].
[ad_2]
